You are here

  • Home
  • Archive
  • Volume 12, Issue 12
  • Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial

Article info

Article menu
Infectious diseases
Protocol
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial

Authors

  • Ameneh Khatami The Children's Hospital at Westmead Department of Infectious Diseases and Microbiology, The Sydney Children's Hospitals Network, Westmead, New South Wales, AustraliaChildren's Hospital Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • David A Foley Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, AustraliaDepartment of Microbiology, PathWest Laboratory Medical WA, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Morgyn S Warner Infectious Diseases Unit, Central Adelaide Local Health Network, Adelaide, South Australia, AustraliaDiscipline of Medicine, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Elizabeth H Barnes NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Anton Y Peleg Infection Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, AustraliaDepartment of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jian Li Infection Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Stephen Stick Wal-yan Respiratory Research Centre, Telethon Kids Institute, Nedlands, Western Australia, AustraliaDepartment of Respiratory and Sleep Medicine, Perth Children's Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Nettie Burke Former CEO, Cystic Fibrosis Australia, North Ryde, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ruby C Y Lin Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCentre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Julia Warning Office for Health and Medical Research, New South Wales Ministry of Health, St Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Thomas L Snelling The Children's Hospital at Westmead Department of Infectious Diseases and Microbiology, The Sydney Children's Hospitals Network, Westmead, New South Wales, AustraliaSchool of Public Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Steven Y C Tong Department of Infectious Diseases, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, AustraliaVictorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jonathan Iredell Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, AustraliaDepartment of Infectious Diseases, Westmead Hospital, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • for the Phage Australia Clinical Network
    Google scholar articles
  1. Correspondence to Dr Ameneh Khatami; ameneh.khatami{at}health.nsw.gov.au
View Full Text

Citation

Khatami A, Foley DA, Warner MS for the Phage Australia Clinical Network, et al
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial
BMJ Open 2022;12:e065401. doi: 10.1136/bmjopen-2022-065401

Publication history

  • Received June 7, 2022
  • Accepted November 29, 2022
  • First published December 9, 2022.
Online issue publication 
December 09, 2022
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.